Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03774836 · ClinicalTrials.gov registry record · Phase 3

Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty

A Phase 3 study of Pain Management, sponsored by Avenue Therapeutics.

Active
Registry status
Phase 3
Development phase
360
Enrollment target
3
Study locations

NCT03774836 is a Phase 3 study of Pain Management that is active but no longer recruiting, run by Avenue Therapeutics. The registered enrollment target is 360 participants, above the 143-participant average among 31 other Pain Management trials with a reported enrollment target (152% higher). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03774836, a Phase 3 study of Pain Management, is active but no longer recruiting, sponsored by Avenue Therapeutics.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
360 participants
Enrollment target
3
Study locations

Study Summary

This study is evaluating the analgesic efficacy of intravenous (IV) tramadol (AVE-901) compared to placebo in the management of postoperative pain following abdominal surgery.

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Morphine
  • DRUG Tramadol

Study Locations (3)

Texas

  • Hermann Drive Research - Houston
  • Endeavor Clinical Trials - San Antonio

California

  • Lotus Clinical Research - Pasadena

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2018-12-14
Est. Completion 2019-06-30
Phase Phase 3

Sponsor

Avenue Therapeutics

3 total trials

What the Registry Record Tells You About NCT03774836

The ClinicalTrials.gov registry entry for NCT03774836 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 143-participant average among 31 other Pain Management trials with a reported enrollment target (152% higher). The listed sponsor is Avenue Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT03774836 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, California.

Frequently Asked Questions

What is clinical trial NCT03774836 about?

NCT03774836 is a clinical study titled "Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty". This study is evaluating the analgesic efficacy of intravenous (IV) tramadol (AVE-901) compared to placebo in the management of postoperative pain following abdominal surgery.

What is the current status of trial NCT03774836?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2018-12-14. Estimated completion is 2019-06-30.

What conditions does trial NCT03774836 study?

This clinical trial studies the following conditions: Pain Management.

What interventions are being tested in trial NCT03774836?

The interventions under investigation include: Placebo (OTHER), Morphine (DRUG), Tramadol (DRUG).

Who is sponsoring clinical trial NCT03774836?

This trial is sponsored by Avenue Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03774836 being conducted?

This trial has 3 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain Management

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.